NXTMH.HE

Nexstim Plc [NXTMH.HE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

NXTMH.HE Stock Summary

Top 10 Correlated Stocks

NXTMH.HE

In the News

NXTMH.HE Financial details

Company Rating
-
Market Cap
15.36M
Income
-2.9M
Revenue
12.36M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
37
Optionable
No
Shortable
Yes
Earnings
06 Mar 2024
P/E
28.18
Forward P/E
-
PEG
-0.9
P/S
3.71
P/B
6.79
P/C
-
P/FCF
-80.61
Quick Ratio
0.71
Current Ratio
1.57
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.43
EPS next Y
-
EPS next Q
-
EPS this Y
-200%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-46.75%
Revenue last 5Y
16.7%
Revenue Q/Q
89.42%
EPS Q/Q
-108.1%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-30.77%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
25%
ROC
0.13%
Gross Margin
100%
Oper. Margin
14%
Profit Margin
14%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.03-3.95
52W High
+203.33%
52W Low
+355%
RSI
56
Rel Volume
0.14
Avg Volume
8.54K
Volume
1.17K
Perf Week
3.88%
Perf Month
-0.55%
Perf Quarter
-35.69%
Perf Half Y
-37.24%
-
-
-
-
Beta
1.349
-
-
Volatility
0.17%, 0.29%
Prev Close
-0.55%
Price
9.1
Change
3.76%

Something similar

Top by Market Cap
VOO
NVD.DE
LLY
BRK-A
CMC.DE
Same Sector
ALLK
WXXWY
096530.KQ
UTMD
AVCN.TO
Top Correlated Stocks
AKSHOPTFBR.NS
0131.HK
DBREALTY.NS
3601.HK
Similar Market Cap
FALC
BEK-B.TO
AIH
ENEDO.HE
CFMS

Company Profile

Healthcare Medical - Devices
  • Volume Average 8.54K
  • Market Capitalization 15.36M
  • Employee 37
  • CEO Mr. Mikko Karvinen
  • Headquarters Helsinki,FI
  • IPO Date 2014-11-14
  • Website https://www.nexstim.com

Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.